Ascendis Pharma A/S (ASND)
USD 163.34
(3.28%)
USD 163.34
(3.28%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -481.44 Million EUR | 17.45% |
| 2022 | -583.19 Million EUR | -52.04% |
| 2021 | -383.57 Million EUR | 8.44% |
| 2020 | -418.95 Million EUR | -92.17% |
| 2019 | -218.01 Million EUR | -67.58% |
| 2018 | -130.09 Million EUR | -5.0% |
| 2017 | -123.89 Million EUR | -80.86% |
| 2016 | -68.5 Million EUR | -108.08% |
| 2015 | -32.92 Million EUR | -240.88% |
| 2014 | -9.65 Million EUR | -336.77% |
| 2013 | 4.07 Million EUR | 226.32% |
| 2012 | 1.25 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -131.03 Million EUR | -50.83% |
| 2024 Q2 | -109.93 Million EUR | 16.53% |
| 2023 Q4 | -86.87 Million EUR | 46.45% |
| 2023 FY | -481.44 Million EUR | 17.45% |
| 2023 Q1 | -110.91 Million EUR | 46.53% |
| 2023 Q2 | -121.43 Million EUR | -9.48% |
| 2023 Q3 | -162.22 Million EUR | -33.59% |
| 2022 Q4 | -207.41 Million EUR | -22.77% |
| 2022 Q3 | -168.95 Million EUR | -107.77% |
| 2022 Q1 | -125.49 Million EUR | -18.33% |
| 2022 Q2 | -81.31 Million EUR | 35.2% |
| 2022 FY | -583.19 Million EUR | -52.04% |
| 2021 Q3 | -80.34 Million EUR | 40.21% |
| 2021 FY | -383.57 Million EUR | 8.44% |
| 2021 Q2 | -134.37 Million EUR | -114.0% |
| 2021 Q1 | -62.79 Million EUR | 54.81% |
| 2021 Q4 | -106.06 Million EUR | -32.0% |
| 2020 Q3 | -121.74 Million EUR | -28.24% |
| 2020 Q4 | -138.96 Million EUR | -14.15% |
| 2020 FY | -418.95 Million EUR | -92.17% |
| 2020 Q2 | -94.93 Million EUR | -49.93% |
| 2020 Q1 | -63.31 Million EUR | 21.21% |
| 2019 Q1 | -53.63 Million EUR | -67.73% |
| 2019 FY | -218.01 Million EUR | -67.58% |
| 2019 Q4 | -80.36 Million EUR | -220.0% |
| 2019 Q3 | -25.11 Million EUR | 57.37% |
| 2019 Q2 | -58.9 Million EUR | -9.82% |
| 2018 FY | -130.09 Million EUR | -5.0% |
| 2018 Q4 | -31.97 Million EUR | 5.86% |
| 2018 Q2 | -22.77 Million EUR | 44.95% |
| 2018 Q1 | -41.37 Million EUR | -21.07% |
| 2018 Q3 | -33.96 Million EUR | -49.13% |
| 2017 Q3 | -33.87 Million EUR | -10.33% |
| 2017 FY | -123.89 Million EUR | -80.86% |
| 2017 Q1 | -25.13 Million EUR | -52.84% |
| 2017 Q2 | -30.7 Million EUR | -22.14% |
| 2017 Q4 | -34.17 Million EUR | -0.88% |
| 2016 Q4 | -16.44 Million EUR | 9.89% |
| 2016 FY | -68.5 Million EUR | -108.08% |
| 2016 Q1 | -20.51 Million EUR | -71.05% |
| 2016 Q3 | -18.25 Million EUR | -37.4% |
| 2016 Q2 | -13.28 Million EUR | 35.25% |
| 2015 Q1 | 1.42 Million EUR | 128.23% |
| 2015 Q4 | -11.99 Million EUR | -64.09% |
| 2015 Q3 | -7.31 Million EUR | 51.39% |
| 2015 Q2 | -15.03 Million EUR | -1157.59% |
| 2015 FY | -32.92 Million EUR | -240.88% |
| 2014 Q1 | -502 Thousand EUR | -122.27% |
| 2014 Q3 | -1.98 Million EUR | 7.39% |
| 2014 Q2 | -2.13 Million EUR | -325.9% |
| 2014 FY | -9.65 Million EUR | -336.77% |
| 2014 Q4 | -5.03 Million EUR | -154.44% |
| 2013 Q3 | 716 Thousand EUR | 29.13% |
| 2013 Q1 | 554.5 Thousand EUR | 0.0% |
| 2013 FY | 4.07 Million EUR | 226.32% |
| 2013 Q4 | 2.25 Million EUR | 214.8% |
| 2013 Q2 | 554.5 Thousand EUR | 0.0% |
| 2012 FY | 1.25 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Agenus Inc. | -245.76 Million USD | -95.9% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -28.857% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -7101.9% |
| Acelyrin, Inc. | -381.64 Million USD | -26.152% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -673.347% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -618.631% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1539.694% |
| IO Biotech, Inc. | -86.08 Million USD | -459.282% |
| Ardelyx, Inc. | -66.06 Million USD | -628.725% |
| Geron Corporation | -184.12 Million USD | -161.476% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -490.153% |
| Innoviva, Inc. | 179.72 Million USD | 367.884% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5563.416% |
| ChromaDex Corporation | -4.93 Million USD | -9649.838% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1023.126% |
| Onconetix, Inc. | -37.4 Million USD | -1186.958% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1119.502% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1204.755% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -326.206% |
| Vaxcyte, Inc. | -402.26 Million USD | -19.684% |
| Pharming Group N.V. | -10.54 Million USD | -4464.344% |
| ContextLogic Inc. | -317 Million USD | -51.876% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -13318.255% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -552.456% |
| AlloVir, Inc. | -190.41 Million USD | -152.837% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1878.065% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -240.474% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -3838366.868% |
| Summit Therapeutics Inc. | -614.92 Million USD | 21.707% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1311.827% |
| Senti Biosciences, Inc. | -92.91 Million USD | -418.136% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1270.083% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -841.079% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -716.252% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1021.151% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2272.712% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -737.11% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -138.822% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1861.647% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -390.537% |
| Elevation Oncology, Inc. | -45.7 Million USD | -953.402% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -827.197% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -3583.078% |
| AbCellera Biologics Inc. | -146.39 Million USD | -228.862% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -2495.948% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -86.73% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1189.36% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -556.396% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1878.065% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -632.072% |
| ESSA Pharma Inc. | -26.58 Million USD | -1711.153% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -845523.002% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1667.556% |
| Structure Therapeutics Inc. | -89.62 Million USD | -437.209% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -784.655% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -359.839% |
| Lantern Pharma Inc. | -15.96 Million USD | -2916.295% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1592.138% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -4721.22% |
| Opthea Limited | -220.24 Million USD | -118.599% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -126.862% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -192.541% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1244.411% |
| Molecular Templates, Inc. | -8.12 Million USD | -5826.231% |
| Scopus BioPharma Inc. | -11.6 Million USD | -4046.892% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 15.955% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -842.941% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -99.472% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -880.145% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1604.901% |
| Alkermes plc | 355.75 Million USD | 235.33% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -9.36% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -4739.76% |
| AnaptysBio, Inc. | -163.61 Million USD | -194.249% |
| Aptorum Group Limited | -2.82 Million USD | -16944.501% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -134.538% |
| Bicycle Therapeutics plc | -180.66 Million USD | -166.488% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -168.885% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -263.375% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1382.059% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1032.976% |
| Chimerix, Inc. | -82.09 Million USD | -486.451% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 774.201% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -979.397% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -371.683% |
| CRISPR Therapeutics AG | -153.61 Million USD | -213.422% |
| Precision BioSciences, Inc. | -61.31 Million USD | -685.151% |
| Dyadic International, Inc. | -6.79 Million USD | -6984.832% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -51336.645% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -199.169% |
| Fortress Biotech, Inc. | -60.63 Million USD | -693.982% |
| Fortress Biotech, Inc. | -60.63 Million USD | -693.982% |
| GT Biopharma, Inc. | -7.59 Million USD | -6237.331% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -6036.687% |
| ImmuCell Corporation | -5.77 Million USD | -8237.325% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2430.085% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3021.0% |
| Incyte Corporation | 597.59 Million USD | 180.564% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -4468.675% |
| Jaguar Health, Inc. | -41.3 Million USD | -1065.731% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -725.909% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -214.688% |
| MiMedx Group, Inc. | 67.43 Million USD | 813.9% |
| MEI Pharma, Inc. | 17.77 Million USD | 2808.106% |
| Mesoblast Limited | -87.95 Million USD | -447.373% |
| Novavax, Inc. | -545.06 Million USD | 11.671% |
| NextCure, Inc. | -62.72 Million USD | -667.576% |
| Precigen, Inc. | -95.9 Million USD | -402.009% |
| PureTech Health plc | -65.69 Million USD | -632.83% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1818.804% |
| Seer, Inc. | -86.27 Million USD | -458.025% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -129.961% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -96.033% |
| Aptose Biosciences Inc. | -51.2 Million USD | -840.198% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -389.783% |
| Soligenix, Inc. | -6.14 Million USD | -7740.224% |
| Century Therapeutics, Inc. | -136.67 Million USD | -252.262% |
| Kura Oncology, Inc. | -152.63 Million USD | -215.432% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -439.63% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 85241.033% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -84512.83% |
| Autolus Therapeutics plc | -208.38 Million USD | -131.039% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -569.625% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -580.058% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2121.926% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -113.739% |
| GRI Bio, Inc. | -13.03 Million USD | -3592.928% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -11544.405% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -288.001% |
| IGM Biosciences, Inc. | -246.41 Million USD | -95.38% |
| INmune Bio, Inc. | -30 Million USD | -1504.395% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -335.466% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1041.038% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2916.272% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -2948.101% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -706.647% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -375.893% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -74.358% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -102.38% |
| Verastem, Inc. | -87.36 Million USD | -451.063% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -788.475% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -198.413% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -312.7% |
| Histogen Inc. | -10.62 Million USD | -4432.972% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -3269.883% |
| Surrozen, Inc. | -43.04 Million USD | -1018.552% |
| Organovo Holdings, Inc. | -14.67 Million USD | -3181.624% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -9364.208% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -819.864% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1805.74% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1687.241% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -5660.943% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -218.66% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -884.03% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1519.67% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -4521.431% |
| Apollomics, Inc. | -172.6 Million USD | -178.936% |
| Amarin Corporation plc | -59.11 Million USD | -714.466% |
| Turnstone Biologics Corp. | -55.2 Million USD | -772.187% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -227.6% |
| Synaptogenix, Inc. | -6.03 Million USD | -7872.952% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -2870.428% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -517.082% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9948.01% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -5630.014% |
| Exelixis, Inc. | 207.76 Million USD | 331.727% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1110.883% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -234.459% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 8.925% |
| NLS Pharmaceutics AG | -12.17 Million USD | -3855.355% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -6076.602% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1465.732% |
| Gritstone bio, Inc. | -138.49 Million USD | -247.64% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -646.835% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -11936.325% |
| Avid Bioservices, Inc. | -140.75 Million USD | -242.051% |
| Insmed Incorporated | -749.56 Million USD | 35.77% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3069.602% |
| MediWound Ltd. | -6.71 Million USD | -7068.657% |
| OmniAb, Inc. | -50.61 Million USD | -851.119% |
| Alector, Inc. | -130.39 Million USD | -269.233% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -323.347% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -828.592% |
| Zai Lab Limited | -334.62 Million USD | -43.879% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -48.601% |
| Aura Biosciences, Inc. | -76.4 Million USD | -530.1% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -105.192% |
| Immunic, Inc. | -93.61 Million USD | -414.301% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -254.284% |
| Veracyte, Inc. | -74.4 Million USD | -547.071% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -6172.476% |
| FibroGen, Inc. | -284.23 Million USD | -69.385% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1735.342% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -6775.958% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2456.443% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 216.058% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2034.547% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1077.141% |
| TG Therapeutics, Inc. | 12.67 Million USD | 3899.298% |
| Galecto, Inc. | -38.34 Million USD | -1155.436% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -2451.929% |
| Fortrea Holdings Inc. | -3.4 Million USD | -14060.206% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -280.158% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -2665.189% |
| XBiotech Inc. | -24.55 Million USD | -1860.529% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -646.835% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -668.103% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -389.146% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2146.917% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -772.297% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 20.637% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -605.365% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -112.523% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2062.104% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -119.128% |
| NexImmune, Inc. | -32.34 Million USD | -1388.502% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -9006.976% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -3327.671% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 112.177% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1887.726% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -312.205% |
| Ainos, Inc. | -13.77 Million USD | -3396.208% |
| Pluri Inc. | -20.88 Million USD | -2204.898% |
| Prothena Corporation plc | -147.02 Million USD | -227.453% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -322.8% |
| Celularity Inc. | -196.29 Million USD | -145.267% |
| Rallybio Corporation | -74.56 Million USD | -545.683% |
| Cue Biopharma, Inc. | -50.73 Million USD | -848.982% |
| MeiraGTx Holdings plc | -84.02 Million USD | -472.967% |
| Omeros Corporation | -117.81 Million USD | -308.654% |
| Humacyte, Inc. | -110.77 Million USD | -334.613% |
| Immunocore Holdings plc | -55.28 Million USD | -770.814% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -2577.085% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1999.546% |
| Blueprint Medicines Corporation | -506.98 Million USD | 5.037% |
| CalciMedica, Inc. | -34.35 Million USD | -1301.307% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -611.41% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -190.397% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -69.969% |
| Pulmatrix, Inc. | -14.12 Million USD | -3309.44% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1267.941% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -482.598% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -0.053% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -359.085% |
| Cytokinetics, Incorporated | -526.24 Million USD | 8.513% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1234.942% |
| Nutriband Inc. | -5.48 Million USD | -8677.018% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1091.111% |
| Vor Biopharma Inc. | -117.86 Million USD | -308.48% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 111.07% |
| Evogene Ltd. | -23.87 Million USD | -1916.194% |
| ProKidney Corp. | -35.46 Million USD | -1257.412% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -302.0% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 25.148% |
| CorMedix Inc. | -46.33 Million USD | -938.962% |
| BioLineRx Ltd. | -60.61 Million USD | -694.283% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -373.194% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1072.374% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1096.915% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -496.957% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -537.501% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -64.771% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1627.102% |
| MediciNova, Inc. | -8.57 Million USD | -5516.824% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -290.541% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -5647.362% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1754.089% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -101.242% |
| Biomea Fusion, Inc. | -117.25 Million USD | -310.598% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 23.166% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1533.907% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -214.338% |
| Absci Corporation | -110.56 Million USD | -335.439% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1496.839% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -377.451% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -104.057% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 3518.397% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -149.504% |
| Allakos Inc. | -185.7 Million USD | -159.259% |
| Imunon, Inc. | -19.51 Million USD | -2367.064% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -394.629% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 553.596% |
| BioAtla, Inc. | -123.46 Million USD | -289.956% |
| NLS Pharmaceutics AG | -12.17 Million USD | -3855.355% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -2894.446% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -47.112% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1203.004% |
| XOMA Corporation | -40.83 Million USD | -1079.121% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -372.609% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -306.24% |
| aTyr Pharma, Inc. | -50.38 Million USD | -855.461% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -449.102% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -217.244% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -102.515% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1270.902% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -5849.71% |
| Akari Therapeutics, Plc | -10 Million USD | -4710.622% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -715008.801% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 270.972% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7123.62% |
| UroGen Pharma Ltd. | -102.24 Million USD | -370.88% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -350.823% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -6090.505% |
| Orgenesis Inc. | -55.36 Million USD | -769.65% |
| Entera Bio Ltd. | -8.88 Million USD | -5316.211% |
| GH Research PLC | -35.58 Million USD | -1252.873% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2210.206% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -522.121% |
| Xencor, Inc. | -126.08 Million USD | -281.837% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -12685.053% |
| Replimune Group, Inc. | -215.79 Million USD | -123.105% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2163.871% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 19288.8% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7123.62% |
| Portage Biotech Inc. | -75.33 Million USD | -539.041% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -5647.362% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -398.109% |
| OncoCyte Corporation | -27.78 Million USD | -1633.008% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -3488.279% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -4228.968% |
| Purple Biotech Ltd. | -19.88 Million USD | -2321.766% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -6759.196% |
| scPharmaceuticals Inc. | -54.81 Million USD | -778.393% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -2650.16% |
| HilleVax, Inc. | -123.56 Million USD | -289.627% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -4663.501% |
| Tharimmune, Inc. | -9.31 Million USD | -5066.243% |
| Genprex, Inc. | -30.86 Million USD | -1460.077% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -104.068% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1499.811% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -26917.228% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -8990.741% |
| OKYO Pharma Limited | -16.82 Thousand USD | -2861319.539% |
| Savara Inc. | -54.69 Million USD | -780.191% |
| Curis, Inc. | -47.41 Million USD | -915.432% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1496.236% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3017.153% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -8545.125% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1514.781% |
| BeiGene, Ltd. | -881.7 Million USD | 45.396% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2160.951% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -10.331% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -509.774% |
| Erasca, Inc. | -125.04 Million USD | -285.028% |
| bluebird bio, Inc. | -211.91 Million USD | -127.191% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -9527.983% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 387.182% |
| DBV Technologies S.A. | -72.72 Million USD | -562.001% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -9527.983% |
| Moderna, Inc. | -4.71 Billion USD | 89.787% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1098.912% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -8355.339% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -697.256% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -332.183% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -255.7% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -904.71% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -240.416% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -150.219% |
| MacroGenics, Inc. | -9.05 Million USD | -5215.158% |
| RenovoRx, Inc. | -10.23 Million USD | -4605.307% |
| Adicet Bio, Inc. | -142.65 Million USD | -237.483% |
| Prime Medicine, Inc. | -198.13 Million USD | -142.992% |
| Aditxt, Inc. | -32.38 Million USD | -1386.827% |
| Adagene Inc. | -18.94 Million USD | -2441.104% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6484.59% |
| Quantum-Si incorporated | -95.96 Million USD | -401.716% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -304.479% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3202.611% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 463.823% |
| SciSparc Ltd. | -5.12 Million USD | -9299.59% |
| Vericel Corporation | -3.18 Million USD | -15030.327% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -400258.408% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1504.537% |
| Generation Bio Co. | -126.61 Million USD | -280.254% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -560.503% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -483.983% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -83.66% |
| Invivyd, Inc. | -198.64 Million USD | -142.368% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -40.785% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -5442.427% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2211.054% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -4775.906% |
| 2seventy bio, Inc. | -217.57 Million USD | -121.284% |
| Clene Inc. | -49.5 Million USD | -872.542% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2060.162% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -873.919% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1754.089% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -46.753% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1379.422% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2219.045% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -387.335% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -544.042% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -199.398% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 21.724% |
| Evaxion Biotech A/S | -22.12 Million USD | -2076.032% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -496.323% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -140.642% |
| Trevena, Inc. | -40.28 Million USD | -1094.984% |
| Surrozen, Inc. | -43.04 Million USD | -1018.552% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -596.397% |
| Cingulate Inc. | -23.53 Million USD | -1945.669% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -6865.379% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1107.845% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -6143.904% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -433.696% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -685.574% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -709.114% |
| Clearmind Medicine Inc. | -11.95 Million USD | -3927.15% |
| Kronos Bio, Inc. | -112.67 Million USD | -327.296% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -595.763% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -18982681.53% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -460.506% |
| Statera Biopharma, Inc. | -174.4 Million USD | -176.046% |
| ImmunityBio, Inc. | -583.19 Million USD | 17.447% |
| Korro Bio, Inc. | -81.17 Million USD | -493.12% |
| Kineta, Inc. | -14.09 Million USD | -3314.76% |
| BioVie Inc. | -32.12 Million USD | -1398.876% |
| Codexis, Inc. | -76.24 Million USD | -531.489% |
| Celularity Inc. | -196.29 Million USD | -145.267% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -124.42% |
| Celcuity Inc. | -63.77 Million USD | -654.866% |
| Virax Biolabs Group Limited | -6.73 Million USD | -7049.987% |
| Cibus, Inc. | -267.62 Million USD | -79.895% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1093.887% |
| IN8bio, Inc. | -30 Million USD | -1504.449% |
| Kodiak Sciences Inc. | -260.49 Million USD | -84.823% |
| Annexon, Inc. | -134.23 Million USD | -258.654% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -310.914% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -686.318% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1426.271% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -31.44% |
| Eyenovia, Inc. | -27.26 Million USD | -1666.059% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2329.85% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -89890.093% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -530.133% |
| Arcellx, Inc. | -70.69 Million USD | -581.068% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1061.765% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -259.783% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1502.846% |
| Moolec Science SA | -51.78 Million USD | -829.634% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -819.301% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1047.012% |
| Royalty Pharma plc | 1.13 Billion USD | 142.424% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -254.12% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -5314.504% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2166.355% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -180.449% |
| Humacyte, Inc. | -110.77 Million USD | -334.613% |
| 89bio, Inc. | -142.18 Million USD | -238.597% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -598.154% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -4539.559% |
| Genelux Corporation | -28.29 Million USD | -1601.407% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1556.449% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -171.821% |
| Notable Labs, Ltd. | -11.26 Million USD | -4174.21% |
| Liquidia Corporation | -78.5 Million USD | -513.293% |
| Mustang Bio, Inc. | -51.6 Million USD | -833.001% |
| Immunovant, Inc. | -259.33 Million USD | -85.646% |
| Quantum-Si incorporated | -95.96 Million USD | -401.716% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -560.883% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -2384.118% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -401.56% |
| Acasti Pharma Inc. | -12.85 Million USD | -3645.795% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2043.78% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2916.272% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -163.961% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -11092.493% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -3760.842% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1532.522% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1134.859% |
| PepGen Inc. | -78.62 Million USD | -512.325% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1517.276% |
| United Therapeutics Corporation | 984.8 Million USD | 148.888% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2062.835% |
| Solid Biosciences Inc. | -96.01 Million USD | -401.429% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9948.01% |
| Immuneering Corporation | -53.47 Million USD | -800.379% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -9364.208% |
| Silo Pharma, Inc. | -3.7 Million USD | -12909.68% |
| Belite Bio, Inc | -31.63 Million USD | -1422.025% |
| XOMA Corporation | -40.83 Million USD | -1079.121% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -785.583% |
| Bionomics Limited | -15.49 Billion USD | 96.892% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -473.254% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1551.223% |
| uniQure N.V. | -308.47 Million USD | -56.072% |
| Cassava Sciences, Inc. | -97.21 Million USD | -395.229% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6484.59% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -290.057% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1429.569% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -5770.086% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1556.278% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -89890.093% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1735.342% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -2820.516% |
| Altimmune, Inc. | -88.44 Million USD | -444.334% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -217.611% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1551.223% |
| Compugen Ltd. | -18.75 Million USD | -2467.17% |
| Peak Bio, Inc. | -1259.26 USD | -38232433.393% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -945.51% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2113.448% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -42.108% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -480.378% |
| Zura Bio Limited | -60.36 Million USD | -697.626% |
| PolyPid Ltd. | -23.86 Million USD | -1917.377% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -2960.304% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -480.378% |
| Instil Bio, Inc. | -156.08 Million USD | -208.448% |
| argenx SE | -295.05 Million USD | -63.173% |
| Immunome, Inc. | -106.8 Million USD | -350.768% |
| Verona Pharma plc | -54.36 Million USD | -785.517% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -381.847% |
| Shattuck Labs, Inc. | -87.29 Million USD | -451.498% |
| CervoMed Inc. | -2.17 Million USD | -22067.364% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -286.236% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -3515.553% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1005.377% |
| Moolec Science SA | -51.78 Million USD | -829.634% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -2784161.609% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -256.318% |
| Design Therapeutics, Inc. | -66.86 Million USD | -620.061% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -491.357% |
| NeurAxis, Inc. | -14.62 Million USD | -3191.567% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1170.912% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1314.606% |
| Achilles Therapeutics plc | -69.66 Million USD | -591.089% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -381.847% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2315.07% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 16101.349% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -18982681.53% |
| Nutriband Inc. | -5.48 Million USD | -8677.018% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -378.115% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -890.489% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -524.518% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1317.271% |
| MoonLake Immunotherapeutics | -36 Million USD | -1237.083% |
| Palisade Bio, Inc. | -12.3 Million USD | -3814.203% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1042.928% |
| Beam Therapeutics Inc. | -132.52 Million USD | -263.282% |
| Neurogene Inc. | -36.31 Million USD | -1225.679% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -194.616% |
| AEON Biopharma, Inc. | -52.55 Million USD | -816.065% |
| Sesen Bio, Inc. | -19.88 Million USD | -2321.278% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -572.562% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -3747.299% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -8.425% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -331.536% |
| Athira Pharma, Inc. | -117.67 Million USD | -309.143% |
| Vaccinex, Inc. | -20.25 Million USD | -2277.399% |
| HCW Biologics Inc. | -24.99 Million USD | -1826.229% |
| XOMA Corporation | -40.83 Million USD | -1079.121% |
| Nektar Therapeutics | -276.05 Million USD | -74.402% |
| Arvinas, Inc. | -367.3 Million USD | -31.077% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -715008.801% |
| Merus N.V. | -154.93 Million USD | -210.733% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -394.157% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1434.004% |
| Rezolute, Inc. | -68.45 Million USD | -603.263% |
| Clene Inc. | -49.5 Million USD | -872.542% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3021.522% |
| BeyondSpring Inc. | -21.02 Million USD | -2189.77% |
| Synlogic, Inc. | -57.28 Million USD | -740.486% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -3945.433% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4347.137% |
| Peak Bio, Inc. | -1259.26 USD | -38232433.393% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1188.394% |
| Krystal Biotech, Inc. | 10.93 Million USD | 4504.016% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -236.443% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -48.09% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -10323.266% |
| MannKind Corporation | -11.93 Million USD | -3932.895% |
| Ikena Oncology, Inc. | -68.16 Million USD | -606.286% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2190.968% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -418.058% |
| Gossamer Bio, Inc. | -179.81 Million USD | -167.743% |
| CohBar, Inc. | -11.96 Million USD | -3924.764% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1766.942% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1496.839% |
| Legend Biotech Corporation | -518.25 Million USD | 7.102% |
| Mural Oncology plc | -207.44 Million USD | -132.082% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -287.904% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -2532.336% |
| Disc Medicine, Inc. | -76.42 Million USD | -529.927% |
| Champions Oncology, Inc. | -7.27 Million USD | -6516.919% |
| REGENXBIO Inc. | -263.49 Million USD | -82.716% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -4436.358% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -913.466% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1167.516% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -380.664% |
| Vaxart, Inc. | -82.46 Million USD | -483.82% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 144348.164% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1182.405% |
| Cellectis S.A. | -101.05 Million USD | -376.402% |
| Longeveron Inc. | -21.41 Million USD | -2148.386% |
| Repare Therapeutics Inc. | -93.79 Million USD | -413.292% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 10.174% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -576.484% |
| Revolution Medicines, Inc. | -436.36 Million USD | -10.331% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -7226.845% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1461.923% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -594.398% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -643.754% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -4807.216% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 113.301% |
| Denali Therapeutics Inc. | -145.22 Million USD | -231.52% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -400258.408% |
| Veru Inc. | -93.15 Million USD | -416.836% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1681.224% |
| Cingulate Inc. | -23.53 Million USD | -1945.669% |
| Passage Bio, Inc. | -102.06 Million USD | -371.72% |
| Context Therapeutics Inc. | -23.96 Million USD | -1909.025% |
| Exicure, Inc. | -16.91 Million USD | -2746.441% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -154.846% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1174.883% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -7298.54% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -160.695% |
| Nuvalent, Inc. | -126.21 Million USD | -281.438% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -4478.383% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -454.158% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1476.241% |
| OmniAb, Inc. | -50.61 Million USD | -851.119% |
| Anew Medical, Inc. | 1.34 Million USD | 35865.401% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -2900.605% |
| Lipocine Inc. | -16.35 Million USD | -2844.255% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -625.136% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -656.101% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1041.038% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -903.705% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2327.749% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 11.088% |
| Ocugen, Inc. | -63.07 Million USD | -663.257% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -402.911% |
| Q32 Bio Inc. | -112.96 Million USD | -326.206% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -2700.413% |
| Alumis Inc. Common Stock | -154.99 Million USD | -210.625% |
| Equillium, Inc. | -13.33 Million USD | -3510.401% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -697.547% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -5927.252% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2453.929% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -714.879% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -320.379% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -2519.699% |
| Dominari Holdings Inc. | -22.88 Million USD | -2004.042% |
| Edesa Biotech, Inc. | -8.37 Million USD | -5649.022% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2277.516% |
| Bio-Techne Corporation | 168.1 Million USD | 386.397% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -36.741% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 473.641% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -295.173% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1169.003% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -327.413% |
| Nkarta, Inc. | -117.5 Million USD | -309.739% |
| BioCardia, Inc. | -11.57 Million USD | -4060.807% |
| Iterum Therapeutics plc | -38.37 Million USD | -1154.716% |